Rapid Immunity Assessment

Elimination of diseases through a systematic campaign of vaccination is an achievable objective.  Regular and accurate measurement of vaccine administration is paramount to determine progress towards immunization goals and identify ineffective segments of delivery systems.  In the developing world, however, current methods used to assess vaccination coverage (e.g., household surveys) and to monitor the incidence of vaccine-preventable diseases (e.g., clinical serological assays) are severely lacking in accuracy due to reporting inflation, low participation, and the significant costs associated with clinical examination.


Diagnostics For All has been awarded a grant by the Bill & Melinda Gates Foundation to develop a low-cost, rapid diagnostic test for immune markers of successful vaccination against tetanus and measles.  The development of a simple, point-of-care immunity assessment assay will have immediate impacts on current global efforts to control vaccine-preventable diseases.